Gnoni, A.; Licchetta, A.; Memeo, R.; Argentiero, A.; Solimando, A.G.; Longo, V.; Delcuratolo, S.; Brunetti, O.
Role of BRAF in Hepatocellular Carcinoma: A Rationale for Future Targeted Cancer Therapies. Medicina 2019, 55, 754.
https://doi.org/10.3390/medicina55120754
AMA Style
Gnoni A, Licchetta A, Memeo R, Argentiero A, Solimando AG, Longo V, Delcuratolo S, Brunetti O.
Role of BRAF in Hepatocellular Carcinoma: A Rationale for Future Targeted Cancer Therapies. Medicina. 2019; 55(12):754.
https://doi.org/10.3390/medicina55120754
Chicago/Turabian Style
Gnoni, Antonio, Antonella Licchetta, Riccardo Memeo, Antonella Argentiero, Antonio G. Solimando, Vito Longo, Sabina Delcuratolo, and Oronzo Brunetti.
2019. "Role of BRAF in Hepatocellular Carcinoma: A Rationale for Future Targeted Cancer Therapies" Medicina 55, no. 12: 754.
https://doi.org/10.3390/medicina55120754
APA Style
Gnoni, A., Licchetta, A., Memeo, R., Argentiero, A., Solimando, A. G., Longo, V., Delcuratolo, S., & Brunetti, O.
(2019). Role of BRAF in Hepatocellular Carcinoma: A Rationale for Future Targeted Cancer Therapies. Medicina, 55(12), 754.
https://doi.org/10.3390/medicina55120754